Gastroparesis comes up in 3 chapters across 3 episodes of The No Agenda Show, from July 2023 to March 2025.
A viral video from a "TikTok Doctor" claims that weight-loss drugs like Ozempic are derived from Gila monster venom and carry risks of thyroid cancer and paralyzed stomachs. While the drug uses a synthetic peptide, reports of gastroparesis have led to increased scrutiny of pharmaceutical marketing.
GLP-1 Side Effects, Novo Nordisk Lawsuit and Pharma Ads
A CBS investigative report detailed severe side effects from GLP-1 weight loss drugs like Ozempic and Wegovy, including a case of stomach paralysis requiring surgery. A Pennsylvania woman is suing manufacturer Novo Nordisk, alleging the company failed to warn patients of these risks. The hosts analyze the report as a potential "brand war" between pharmaceutical companies as they compete for the lucrative weight loss market.
Reports of gastroparesis, or stomach paralysis, have emerged among users of weight loss drugs like Ozempic and Wegovy. Dr. Darien Sutton explained that while these medications work by slowing gastric emptying, some patients experience severe complications requiring hospitalization. Despite these reports, medical contributors maintain that larger studies have not yet proven a definitive cause-and-effect relationship beyond the general population.
For AI agents: this site has a plain-text version made for you. This page in markdown: https://search.noagendashow.net/topic/gastroparesis.md. Search every episode transcript: https://search.noagendashow.net/search.md?q={query}. How to use the site, with timestamped links to quote: https://search.noagendashow.net/llms.txt.
